Skip to content

The effectiveness of olive oil on controlling of morning inflammatory pain of phalanges and knees among women with rheumatoid arthritis

Study of the effectiveness of olive oil, Paraffin, Pyroxicom and dry massage on controlling of morning inflammatory pain of phalanges and knees among women with rheumatoid arthritis (R.A): A Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110134519N3
Enrollment
60
Registered
2013-02-02
Start date
2012-05-16
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis. Seropositive , unspecified

Interventions

Intervention 1: G 2: routine drugs + Paraffin oil ( 5 ml/ q8h). Intervention 2: G1: routine drugs (prednisolon tab. 5-7.5 mg/daily
Hydrochlorokine tab. 200mg/daily
Metotraxate tab. 7.5 mg/daily and Folic Acid tab. 5 mg/daily) + knee massage with olive oil (5 ml/ q8h). Intervention 3: G5: routine drugs + Pyroxicam jel ( 5 cm/ q8h). Intervention 4: G3 (control g
Treatment - Other
Treatment - Drugs
G 2: routine drugs + Paraffin oil ( 5 ml/ q8h)
G1: routine drugs (prednisolon tab. 5-7.5 mg/daily
Metotraxate tab. 7.5 mg/daily and Folic Acid tab. 5 mg/daily) + knee massage with olive oil (5 ml/ q8h)
G5: routine drugs + Pyroxicam jel ( 5 cm/ q8h)
G3 (control group): only routine drugs
G4: routine drugs + dry massage of knee

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
39 Years to 66 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: to be Volunteer ; At least one year passed from their disease diagnosis and be under consideration of one rheumatologist ; without neuromuscular diseases ; to be able to massage their own hands and knees Exclusion Criteria: Suffering from Osteoartheritis; Inability for hand and foot massage by herself; suffering from incurable diseases

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 3 months. Method of measurement: VAS.

Secondary

MeasureTime frame
Disease Activity Score. Timepoint: 3 months. Method of measurement: DAS 28.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Davood Hekmatpou

Arak University of Medical Sciences

dr_hekmat@arakmu.ac.ir+98 86 1417 3645

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026